Although BIRC3 inhibitors show promise in treating rheumatoid arthritis, potential side effects must be carefully considered, such as inducing apoptosis in normal cells dependent on BIRC3-regulated pathways and triggering adverse immune responses due to its role in immune regulation. The gene discussed is BIRC3; the disease is rheumatoid arthritis.